Put up against placebo in the phase 3 EMBARK trial, delandistrogene moxeparvovec (Elevidys) did not significantly improve ...
Health officials on Saturday said they have identified the first U.S. case of an mpox strain that has recently prompted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback